Aspen Grove Capital’s Procter & Gamble PG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$398K Buy
2,716
+211
+8% +$30.7K 0.06% 130
2026
Q1
$362K Buy
2,505
+75
+3% +$11.4K 0.07% 121
2025
Q4
$348K Sell
2,430
-108
-4% -$15.9K 0.06% 122
2025
Q3
$390K Sell
2,538
-1,321
-34% -$206K 0.07% 112
2025
Q2
$615K Buy
3,859
+1,500
+64% +$245K 0.1% 93
2025
Q1
$402K Sell
2,359
-222
-9% -$37.2K 0.08% 132
2024
Q4
$433K Buy
2,581
+30
+1% +$5.11K 0.09% 113
2024
Q3
$442K Buy
2,551
+1
+0% +$170 0.1% 114
2024
Q2
$421K Buy
2,550
+117
+5% +$19.1K 0.1% 117
2024
Q1
$395K Buy
2,433
+102
+4% +$16K 0.11% 115
2023
Q4
$337K Sell
2,331
-77
-3% -$11.4K 0.1% 115
2023
Q3
$351K Sell
2,408
-1,085
-31% -$166K 0.13% 106
2023
Q2
$530K Buy
3,493
+608
+21% +$91.6K 0.17% 109
2023
Q1
$429K Buy
2,885
+707
+32% +$101K 0.19% 95
2022
Q4
$330K Buy
+2,178
New +$305K 0.15% 104

Other funds holding PG

Aspen Grove Capital's PG Position: Q2 2026 in Review

Aspen Grove Capital increased its Procter & Gamble (PG) stake by 8.4% in Q2 2026, buying an estimated $30.7K and bringing the position to 2,716 shares worth $398K. The position accounts for 0.06% of the portfolio, ranked #130.

Aspen Grove Capital first reported a position in PG in Q4 2022 and has held it in 15 quarters since. The position peaked at $615K in Q2 2025. 3,999 funds tracked by Wall St. Rank hold PG as of Q2 2026.

  • Aspen Grove Capital held 2,716 shares of Procter & Gamble worth $398K as of Q2 2026.
  • Aspen Grove Capital bought 211 Procter & Gamble shares in Q2 2026, an estimated $30.7K.
  • Procter & Gamble made up 0.06% of Aspen Grove Capital's portfolio in Q2 2026, its #130 holding.
  • Aspen Grove Capital first reported a position in Procter & Gamble in Q4 2022 and has held it in 15 quarters since.
  • Aspen Grove Capital's Procter & Gamble position peaked at $615K in Q2 2025.
  • 3,999 funds tracked by Wall St. Rank held Procter & Gamble as of Q2 2026.

Based on Aspen Grove Capital's 13F filing for Q2 2026, filed 14 Aug 2026.